江中药业
(600750)
| 流通市值：138.44亿 | | | 总市值：140.14亿 |
| 流通股本：6.27亿 | | | 总股本：6.35亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,184,099,207.93 | 4,435,450,590.73 | 2,971,879,125.96 | 2,172,527,003.86 |
| 营业收入 | 1,184,099,207.93 | 4,435,450,590.73 | 2,971,879,125.96 | 2,172,527,003.86 |
| 二、营业总成本 | 856,909,058.25 | 3,461,306,482.83 | 2,215,871,404.32 | 1,596,488,140.46 |
| 营业成本 | 376,367,397.16 | 1,617,993,300.84 | 960,827,878.54 | 672,575,771.74 |
| 税金及附加 | 17,547,336.76 | 64,293,434.88 | 45,306,073.46 | 32,374,634.39 |
| 销售费用 | 400,263,845.92 | 1,494,915,537.25 | 1,055,073,662.22 | 780,764,999.85 |
| 管理费用 | 53,445,413.71 | 228,997,968.8 | 136,350,486.78 | 86,537,186.63 |
| 研发费用 | 26,946,333.64 | 130,427,615.7 | 77,862,125.99 | 65,053,345.45 |
| 财务费用 | -17,661,268.94 | -75,321,374.64 | -59,548,822.67 | -40,817,797.6 |
| 其中:利息费用 | 232,609.81 | 1,705,672.02 | 251,878.63 | 231,233.51 |
| 其中:利息收入 | 18,021,892.03 | 77,477,542.83 | 60,125,118.16 | 41,266,593.04 |
| 加:公允价值变动收益 | 48,077.27 | -8,626,804.43 | 844,285.11 | 844,284.98 |
| 加:投资收益 | 110,555.15 | -2,828,979.93 | -2,610,311.3 | -1,438,563.16 |
| 资产处置收益 | 188.9 | 1,837,913.47 | -292,779.09 | 70,261.6 |
| 资产减值损失(新) | -832,937.66 | -16,072,851.21 | -8,039,897.43 | -7,606,008.65 |
| 信用减值损失(新) | -372,880.48 | 14,465,586.18 | 23,030,379.12 | 23,864,648.3 |
| 其他收益 | 33,067,619.71 | 65,378,991.83 | 37,912,830.81 | 24,407,890.93 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 359,210,772.57 | 1,028,297,963.81 | 806,852,228.86 | 616,181,377.4 |
| 加:营业外收入 | 450,854.51 | 8,212,304.63 | 6,030,370.64 | 4,822,992.84 |
| 减:营业外支出 | 667,166.86 | 10,897,474.64 | 5,319,029.77 | 1,164,611.75 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 358,994,460.22 | 1,025,612,793.8 | 807,563,569.73 | 619,839,758.49 |
| 减:所得税费用 | 52,298,952.13 | 165,105,804.49 | 123,670,699.18 | 95,419,669.27 |
| 六、净利润 | 306,695,508.09 | 860,506,989.31 | 683,892,870.55 | 524,420,089.22 |
| 持续经营净利润 | 306,695,508.09 | 860,506,989.31 | 683,892,870.55 | 524,420,089.22 |
| 归属于母公司股东的净利润 | 284,914,263.9 | 788,192,557.44 | 634,340,897.79 | 488,753,443.17 |
| 少数股东损益 | 21,781,244.19 | 72,314,431.87 | 49,551,972.76 | 35,666,646.05 |
| (一)基本每股收益 | 0.45 | 1.25 | 1.01 | 0.78 |
| (二)稀释每股收益 | 0.45 | 1.25 | 1.01 | 0.78 |
| 九、综合收益总额 | 306,695,508.09 | 860,506,989.31 | 683,892,870.55 | 524,420,089.22 |
| 归属于母公司股东的综合收益总额 | 284,914,263.9 | 788,192,557.44 | 634,340,897.79 | 488,753,443.17 |
| 归属于少数股东的综合收益总额 | 21,781,244.19 | 72,314,431.87 | 49,551,972.76 | 35,666,646.05 |
| 公告日期 | 2025-04-26 | 2025-03-20 | 2024-10-26 | 2024-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |